Literature DB >> 24453536

The prolonged intake of L-arginine-L-aspartate reduces blood lactate accumulation and oxygen consumption during submaximal exercise.

Martin Burtscher1, Fritz Brunner1, Martin Faulhaber1, Barbara Hotter1, Rudolf Likar1.   

Abstract

L-arginine-L-aspartate is widely used by athletes for its potentially ergogenic properties. However, only little information on its real efficacy is available from controlled studies. Therefore, we evaluated the effects of prolonged supplementation with L-arginine-L-aspartate on metabolic and cardiorespiratory responses to submaximal exercise in healthy athletes by a double blind placebo-controlled trial. Sixteen healthy male volunteers (22 ± 3 years) performed incremental cycle spiroergometry up to 150 watts before and after intake of L-arginine-L-aspartate (3 grams per day) or placebo for a period of 3 weeks. After intake of L-arginine-L-aspartate, blood lactate at 150 watts dropped from 2.8 ± 0.8 to 2.0 ± 0.9 mmol·l(-1) (p < 0.001) and total oxygen consumption during the 3-min period at 150 watts from 6.32 ± 0.51 to 5.95 ± 0.40 l (p = 0.04) compared to placebo (2.7 ± 1.1 to 2.7 ± 1.4 mmol·l(-1); p = 0.9 and 6.07 ± 0.51 to 5.91 ± 0.50 l; p = 0.3). Additionally, L-arginine-L-aspartate supplementation effected an increased fat utilisation at 50 watts. L-arginine and L-aspartate seem to have induced synergistic metabolic effects. L-arginine might have reduced lactic acid production by the inhibition of glycolysis and L-aspartate may have favoured fatty acid oxidation. Besides, the results indicate improved work efficiency after L-arginine-L-aspartate intake. The resulting increases of submaximal work capacity and exercise tolerance may have important implications for athletes as well as patients. Key PointsAmino acids are among the most common nutritional supplements taken by athletes. They are involved in numerous metabolic pathways that affect exercise metabolism.Three weeks of L-arginine-L-aspartate supplementation resulted in lower blood lactate concentrations and oxygen consumption, diminished glucose and enhanced fat oxidation, and reduced heart rate and ventilation during submaximal cycle exercise.This implies increased submaximal work capacity and exercise tolerance, which may have important implications for both athletes as well as patients.

Entities:  

Keywords:  Nutrition; amino acids; ergogenic; performance; supplementation

Year:  2005        PMID: 24453536      PMCID: PMC3887335     

Source DB:  PubMed          Journal:  J Sports Sci Med        ISSN: 1303-2968            Impact factor:   2.988


  28 in total

Review 1.  Amino acids and endurance exercise.

Authors:  M H Hargreaves; R Snow
Journal:  Int J Sport Nutr Exerc Metab       Date:  2001-03       Impact factor: 4.599

2.  Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run.

Authors:  P C Colombani; R Bitzi; P Frey-Rindova; W Frey; M Arnold; W Langhans; C Wenk
Journal:  Eur J Nutr       Date:  1999-12       Impact factor: 5.614

3.  Effect of arginine aspartate on the exercise-induced hyperammoniemia in humans: a two periods cross-over trial.

Authors:  C Denis; D Dormois; M T Linossier; J L Eychenne; P Hauseux; J R Lacour
Journal:  Arch Int Physiol Biochim Biophys       Date:  1991-02

Review 4.  Amino acid supplementation and exercise performance. Analysis of the proposed ergogenic value.

Authors:  R B Kreider; V Miriel; E Bertun
Journal:  Sports Med       Date:  1993-09       Impact factor: 11.136

5.  Effect of L-NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse.

Authors:  C A Kindig; P McDonough; H H Erickson; D C Poole
Journal:  J Appl Physiol (1985)       Date:  2001-08

Review 6.  Carbohydrates, branched-chain amino acids, and endurance: the central fatigue hypothesis.

Authors:  J M Davis
Journal:  Int J Sport Nutr       Date:  1995-06

7.  The effects of oral administration of salts of aspartic acid on the metabolic response to prolonged exhausting exercise in man.

Authors:  R J Maughan; D J Sadler
Journal:  Int J Sports Med       Date:  1983-05       Impact factor: 3.118

8.  Nitric oxide release is present from incubated skeletal muscle preparations.

Authors:  T W Balon; J L Nadler
Journal:  J Appl Physiol (1985)       Date:  1994-12

9.  L-arginine reduces exercise-induced increase in plasma lactate and ammonia.

Authors:  A Schaefer; F Piquard; B Geny; S Doutreleau; E Lampert; B Mettauer; J Lonsdorfer
Journal:  Int J Sports Med       Date:  2002-08       Impact factor: 3.118

Review 10.  Overtraining and the BCAA hypothesis.

Authors:  U A Gastmann; M J Lehmann
Journal:  Med Sci Sports Exerc       Date:  1998-07       Impact factor: 5.411

View more
  6 in total

Review 1.  The effect of nitric-oxide-related supplements on human performance.

Authors:  Raúl Bescós; Antoni Sureda; Josep A Tur; Antoni Pons
Journal:  Sports Med       Date:  2012-02-01       Impact factor: 11.136

Review 2.  L-Arginine as a potential ergogenic aid in healthy subjects.

Authors:  Thiago S Álvares; Cláudia M Meirelles; Yagesh N Bhambhani; Vânia M F Paschoalin; Paulo S C Gomes
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

3.  No effect of acute L-arginine supplementation on O₂ cost or exercise tolerance.

Authors:  Anni Vanhatalo; Stephen J Bailey; Fred J DiMenna; Jamie R Blackwell; Gareth A Wallis; Andrew M Jones
Journal:  Eur J Appl Physiol       Date:  2013-02-20       Impact factor: 3.078

Review 4.  Aspartate as an ergogenic supplement.

Authors:  François Trudeau
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

5.  The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.

Authors:  Shahla Rezaei; Maryam Gholamalizadeh; Reza Tabrizi; Peyman Nowrouzi-Sohrabi; Samira Rastgoo; Saeid Doaei
Journal:  Physiol Rep       Date:  2021-02

6.  Pre-exercise arginine supplementation increases time to exhaustion in elite male wrestlers.

Authors:  H U Yavuz; H Turnagol; A H Demirel
Journal:  Biol Sport       Date:  2014-07-15       Impact factor: 2.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.